Kazia Therapeutics Shares float
What is the Shares float of Kazia Therapeutics?
The Shares float of Kazia Therapeutics Limited is 116.518M 88.25%
What is the definition of Shares float?
Shares float is the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock.
= annual shares outstanding - closely held shares
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Shares float of companies in the Health Care sector on ASX compared to Kazia Therapeutics
What does Kazia Therapeutics do?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Companies with shares float similar to Kazia Therapeutics
- CMC Metals has Shares float of 116.280M 113.77%
- Angkor Resources has Shares float of 116.362M 75.05%
- Generex Biotechnology has Shares float of 116.432M 98.30%
- Coromandel International has Shares float of 116.462M 39.68%
- Leucrotta Exploration has Shares float of 116.483M 47.04%
- Tower Resources has Shares float of 116.501M 89.71%
- Kazia Therapeutics has Shares float of 116.518M 88.25%
- Broadridge Solutions has Shares float of 116.518M 99.80%
- Bajaj Auto has Shares float of 116.563M 40.28%
- Capital Power has Shares float of 116.585M 99.77%
- Northern Graphite has Shares float of 116.627M 96.18%
- the Rubicon Project has Shares float of 116.672M 88.51%
- Albemarle has Shares float of 116.698M 109.88%